Wisconsin Administrative Code › Optometry Examining Board › Chapter Opt 8 - Continuing Education › Section Opt 8.02 - Continuing education requirements

Current through June 24, 2024
(1) A licensee
			 shall complete 30 hours of approved continuing education in each biennial
			 registration period. A minimum of 20 of the 30 hours shall relate to ocular
			 health, conditions, or disease management.
Note:
Opt 8.02 (title) and (1) are shown as
				amended eff. 12-15-19 by CR 18-021. Prior to 12-15-19 they read:
Opt 8.02 Continuing education.
(1) A licensee shall complete 30 hours of
			 approved continuing education in each biennial registration period. A minimum
			 of 7 of the 30 hours shall be approved glaucoma education.
(1m) During the biennial registration period
			 commencing December 15, 2019 and ending December 14, 2021, unless granted a
			 hardship waiver in accordance with sub. (3m), the 30 required hours of
			 continuing education shall include 2 hours on the topic of responsible
			 prescribing of controlled substances.
Note:
Sub. (1m) is created eff. 12-15-19 by CR
				18-021.
(2) A minimum of 20
			 of the 30 hours of approved continuing education hours, as specified in sub.
			 (1), required for optometrists who are allowed to use diagnostic and
			 therapeutic pharmaceutical agents shall relate to ocular health, conditions, or
			 disease management, or the removal of superficial foreign bodies from an eye or
			 from an appendage to the eye.
Note:
Sub. (2) is shown as amended eff. 12-15-19
				by CR 18-021. Prior to 12-15-19 it reads:
(2) Except as provided in sub. (4), approved
			 continuing education hours required for optometrists who are allowed to use
			 diagnostic and therapeutic pharmaceutical agents shall relate to the diagnosis
			 and management of eye disease or the removal of superficial foreign bodies from
			 an eye or from an appendage to the eye.
(3) A minimum of 20 of the 30 hours of
			 approved continuing education hours, as specified in sub. (1), required for
			 optometrists who are not allowed to use diagnostic and therapeutic
			 pharmaceutical agents shall relate to ocular health, conditions, or disease
			 management.
Note:
Sub. (3) is shown as amended eff. 12-15-19
				by CR 18-021. Prior to 12-15-19 it reads:
(3) Except as provided in sub. (4), approved
			 continuing education hours required for optometrists who are not allowed to use
			 diagnostic and therapeutic pharmaceutical agents shall relate to the diagnosis
			 and management of eye disease.
(3e)
			 At least 20 of the 30 hours of approved continuing education required under
			 sub. (1) shall be completed by attending programs in person. Any programs not
			 completed in person shall be COPE or Joint Accreditation for Interprofessional
			 Continuing Education approved programs, in accordance with s.
			 Opt
			 8.03(1) (a), or programs approved
			 under s.
			 Opt
			 8.03(2).
Note:
Sub. (3e) is created eff. 12-15-19 by CR
				18-021.
(3m) In cases of
			 hardship, a licensee may apply to the board for any of the following:
(a) Approval of less than the 20 hours of in
			 person continuing education required under sub. (3e).
(b) Approval of a continuing education
			 program under s.
			 Opt
			 8.03(2).
Note:
Sub. (3m) is created eff. 12-15-19 by CR
				18-021.